0001213900-23-098456.txt : 20231226 0001213900-23-098456.hdr.sgml : 20231226 20231226120458 ACCESSION NUMBER: 0001213900-23-098456 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20231226 DATE AS OF CHANGE: 20231226 EFFECTIVENESS DATE: 20231226 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Temple Therapeutics Holdings Ltd CENTRAL INDEX KEY: 0001896459 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-500709 FILM NUMBER: 231512033 BUSINESS ADDRESS: STREET 1: URMONDERBAAN22 GATE 2 CITY: GELEEN STATE: P7 ZIP: 6161RD BUSINESS PHONE: 306-261-5189 MAIL ADDRESS: STREET 1: URMONDERBAAN22 GATE 2 CITY: GELEEN STATE: P7 ZIP: 6161RD D 1 primary_doc.xml X0708 D LIVE 0001896459 Temple Therapeutics Holdings Ltd URMONDERBAAN 22, GATE 2 GELEEN P7 NETHERLANDS 6167 RD 3062615189 CAYMAN ISLANDS None None Corporation true 2020 Sanj Singh 1006 Emmeline Place Saskatoon A9 SASKATCHEWAN, CANADA S7J5G7 Executive Officer Director Biotechnology No Revenues 06b false 2023-12-19 false true false 25000 TerraNova Capital Equities, lnc. 45097 None None 420 LEXINGTON AVENUE SUITE 1402 NEW YORK NY NEW YORK 10170 AL ALABAMA AK ALASKA AZ ARIZONA AR ARKANSAS CA CALIFORNIA CO COLORADO CT CONNECTICUT FL FLORIDA GA GEORGIA HI HAWAII ID IDAHO IL ILLINOIS IN INDIANA KS KANSAS KY KENTUCKY LA LOUISIANA MI MICHIGAN MN MINNESOTA MS MISSISSIPPI MO MISSOURI MT MONTANA NH NEW HAMPSHIRE NJ NEW JERSEY NM NEW MEXICO NY NEW YORK NC NORTH CAROLINA OH OHIO OR OREGON PA PENNSYLVANIA SC SOUTH CAROLINA TX TEXAS UT UTAH VT VERMONT VA VIRGINIA WA WASHINGTON WI WISCONSIN false 5000000 25000 4975000 false 1 210000 true 0 The reported sales commissions fee is equal to 4.2% of the total amount sold in the offering. 0 false Temple Therapeutics Holdings Ltd /s/ SANJ SINGH SANJ SINGH CEO, DIRECTOR 2023-12-26